Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nr23
    Member
    • Oct 2012
    • 42

    #1

    When to merge specify replicates

    Hi,

    I've got RNA-Seq data (pe 100bp) from several biological replicates and 11 different conditions and want to compare DE between conditions.

    I'm using the tuxedo suite (tophat, cufflinks) and wanted to know if I should run both replicates through tophat at the same time (specified as reps) , and use the output for cufflinks, or separately, and specify them as replicates in cufflinks?

    Additionally, the samples have been multiplexed (so each replicate is split over two lanes) - and I've currently merged the multiplexed reads for each replicate - do I lose power by doing this?

    Any advice would be great!

    Thanks,

    N
    Last edited by nr23; 06-05-2013, 01:49 AM.
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    Keep your biological replicates separate, and treat them as replicates. Otherwise, there was little point in even running them as you will have completely obscured the biological variation amongst your samples.

    Merging all your multiplexed lanes per sample prior to mapping them is fine and then you can map them all as the single sample they represent.
    Last edited by mbblack; 05-29-2013, 04:52 AM.
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    • mastal
      Senior Member
      • Mar 2009
      • 666

      #3
      When to merge specify replicates

      How many lanes were used in all? Were all of the samples run in the same two lanes?

      You shouldn't combine biological replicates when running Tophat. You need the replicates in order to estimate the variance when calculating DE.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...